Skip to content
TrialScanner

NCT02157714

Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease

Phase 1CompletedPRTALead

Registry record

Lead sponsor
Prothena Biosciences Limited
Conditions
Parkinson's Disease
Primary completion
Sep 2016Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02157714 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02157714: Multiple Ascending Dose... | TrialScanner